Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Complications Post Transplant

Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy

Abstract

Late side-effects of stem cell transplantation include hypogonadism with infertility and sexual dysfunction, but gynaecomastia is less well recognised. We report five cases of gynaecomastia with features of hypergonadotrophic hypogonadism (primary testicular failure), who received either a TBI/cyclophosphamide conditioned allograft (n = 3) or a BEAM autograft (n = 2). Patients receiving an allograft had gynaecomastia, Leydig cell insufficiency (LCI) diminished libido and erectile dysfunction. Surgery was required in one case, while in two cases the gynaecomastia resolved spontaneously after 6 months. Two patients also had gynaecomastia and sexual dysfunction, severe hypogonadism, very low testosterone levels and marked hyperprolactinaemia following autoBMT. Both responded well to testosterone replacement therapy (TRT). As a group, all patients had primary testicular failure and all except one, had LCI (compensated or frank). However, there was no correlation between the severity of gynaecomastia and the degree of endocrine dysfunction. This preliminary study is the first to suggest that gynaecomastia, due to primary hypogonadism and LCI, may be a significant complication of myeloablative conditioning therapy. Therefore gynaecomastia in BMT recipients must always be treated as a pathological entity as it may be the external manifestation of a complex endocrine pathology. It is a potentially treatable condition. Although spontaneously reversible, some patients may require TRT or even surgery. We recommend comprehensive endocrine testing in conjunction with a reproductive endocrinologist and prompt intervention to alleviate embarrassment and anxiety in afflicted BMT recipients.

Bone Marrow Transplantation (2001) 28, 1141–1144.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Howell SJ, Shalet SM . Gonadal damage from chemotherapy and radiotherapy Endocrinol Metab Clin North Am 1998 27: 927–943

    Article  CAS  Google Scholar 

  2. Chatterjee R, Goldstone AH . Gonadal damage and effects on fertility after bone marrow transplantation Bone Marrow Transplant 1996 17: 5–11

    CAS  PubMed  Google Scholar 

  3. Mills W, Chatterjee R, McGarrigle HHG et al. Partial hypopituitarism following TBI in adult patients with haematological malignancy Bone Marrow Transplant 1994 14: 471–473

    CAS  PubMed  Google Scholar 

  4. Littley MD, Shalet SM, Beardwell CG et al. Hypopituitarism following external radiotherapy for pituitary tumours in adults Q J Med 1989 262: 145–160

    Google Scholar 

  5. Chatterjee R, Kottaridis PD, McGarrigle HH, Goldstone AH . Patterns of Leydig cell insufficiency in adult males, following bone marrow transplantation for haematological malignancies Bone Marrow Transplant 2001 28: 497–502

    Article  CAS  Google Scholar 

  6. Anderson A, Groom JB . Male breast at autopsy Acta Pathol Microbiol Immunol Scand 1982 90: 191–210

    Google Scholar 

  7. Nuttal FQ . Gynaecomastia as a physical finding in normal men J Clin Endocrinol Metab 1979 48: 338–348

    Article  Google Scholar 

  8. Chatterjee R, Kottaridis PD, Lees WR et al. Cavernosal arterial insufficiency and erectile dysfunction in recipients of high dose chemotherapy and total body irradiation for multiple myeloma Lancet 2000 355: 1335–1336

    Article  CAS  Google Scholar 

  9. Simon BE, Hoffman S, Kahn S . Classification and surgical correction of gynaecomastia Plast Reconstr Surg 1973 51: 48–52

    Article  CAS  Google Scholar 

  10. Faiman C, Winters JSD . Diurnal cycles in plasma FSH, testosterone and cortisol in men J Clin Endocrinol Metab 1971 33: 186–192

    Article  CAS  Google Scholar 

  11. Miyatake A, Morimoto Y, Oishi T et al. Circadian rhythm of serum testosterone, and its relation to sleep: comparison with the variation in serum luteinising hormone, prolactin, and cortisol in normal men J Clin Endocrin Metab 1980 54: 1365–1371

    Article  Google Scholar 

  12. Urban MD, Lee PA, Korasky AA et al. Comparison of estimates of gonadotrophin levels by isolated blood samples, integrated blood concentrations and timed urinary fractions J Clin Endocrinol Metab 1979 48: 732–735

    Article  CAS  Google Scholar 

  13. Chatterjee R, Mills W, Katz M et al. Germ cell failure and Leydig cell insufficiency in post-pubertal males after autolagous bone marrow transplantation with BEAM for lymphoma Bone Marrow Transplant 1994 13: 519–522

    CAS  PubMed  Google Scholar 

  14. Glass AR . Gynaecomastia Endocrinol Metab Clin North Am 1994 23: 825–837

    Article  CAS  Google Scholar 

  15. Vanderpump MPJ, Tunbridge WMG . The effects of drugs on endocrine system (review) Clin Endocrinol 1993 39: 389–397

    Article  CAS  Google Scholar 

  16. Aki FT, Tekin ML, Ozen H . Gynaecomastia as a complication of chemotherapy for testicular germ cell tumours Urology 1996 48: 944–946

    Article  CAS  Google Scholar 

  17. Chan WB, Yeung VT, Chow CC et al. Gynaecomastia as a presenting feature of thyrotoxicosis Postgrad Med J 1999 75: 229–231

    Article  CAS  Google Scholar 

  18. Galbraith RA, Michnovich JJ . The effect of cimertidine on the oxidative metabolism of oestradiol New Engl J Med 1989 321: 269–274

    Article  CAS  Google Scholar 

  19. Knigge U, Dejgaard A, Wollesen F et al. The acute and long term effect of the H2-receptor antagonists cimetidine and ranitidine on the pituitary gonadal axis in men Clin Endocrinol 1983 18: 307–313

    Article  CAS  Google Scholar 

  20. Reiter WJ, Pycha A, Schatzl G et al. Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double blind, randomized, placebo-controlled study Urology 1999 53: 590–594

    Article  CAS  Google Scholar 

  21. Hafez B . Recent advances in clinical/molecular andrology Arch Andro 1998 40: 187–210

    Article  CAS  Google Scholar 

  22. Aversa A, Isidori AM, De Martino MU et al. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilatation in men with erectile dysfunction Clin Endocrinol 2000 53: 517–522

    Article  CAS  Google Scholar 

  23. Jannini EA, Screponi E, Carosa E et al. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone Int J Androl 1999 22: 385–392

    Article  CAS  Google Scholar 

  24. Gasperoni C, Slagarello M, Gasperoni P . Technical refinements in the surgical treatment of gynaecomastia Ann Plast Surg 2000 44: 455–458

    Article  CAS  Google Scholar 

  25. Javaid M, Sdhibu M . Surgical correction of gynaecomastia: a new approach Br J Plastic Surg 2000 53: 174–175

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harris, E., Mahendra, P., McGarrigle, H. et al. Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy. Bone Marrow Transplant 28, 1141–1144 (2001). https://doi.org/10.1038/sj.bmt.1703302

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703302

Keywords

This article is cited by

Search

Quick links